Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. A. M. Olde Nordkamp
Cancer Patients Treated With Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Thyroid Dysfunction in Patients Treated With Sunitinib or Sorafenib
Clinical Genitourinary Cancer
Oncology
Urology
Hypothyroidism Side Effect in Patients Treated With Sunitinib or Sorafenib: Clinical and Structural Analyses
PLoS ONE
Multidisciplinary
Reply to Influenza Vaccination in Patients With Cancer
Cancer
Cancer Research
Oncology
Acquired Immune Responses to the Seasonal Trivalent Influenza Vaccination in COPD
Clinical and Experimental Immunology
Allergy
Immunology
Vaccination With Dengue Virus-Like Particles Induces Humoral and Cellular Immune Responses in Mice
Virology Journal
Virology
Infectious Diseases
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Immune Responses to Polyclonal T-Cell Vaccination in Patients With Progressive Multiple Sclerosis
Journal of Immunotoxicology
Toxicology
Immunology
Immune Responses to Avian Influenza Viruses
Journal of Immunology
Allergy
Immunology
Cellular and Mucosal Immune Responses Following Vaccination With Inactivated Mutant of Escherichia Coli O157:H7
Scientific Reports
Multidisciplinary